P14780 (MMP9_HUMAN) Homo sapiens (Human)

Matrix metalloproteinase-9 UniProtKBInterProSTRINGInteractive Modelling

707 aa; Sequence (Fasta)

Available Structures

29 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to M…
5th9
 Heteromer
40-443
2×ZN; 2×CA; 1×NCO;
Assess
Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.
4h82
homo-2-mer110-444
4×ZN; 6×CA; 1×L29;
Assess
Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalyt…
4hma
homo-2-mer110-444
4×ZN; 6×CA; 1×0ZD; 5×GOL; 6×PGO; 7×PEG; 1×MLT;
Assess
MMP9 active site mutant-inhibitor complex
1gkd
homo-2-mer110-443
8×CA; 2×STN; 2×BUM; 4×ZN;
Assess
Dimeric form of the haemopexin domain of MMP9
1itv
homo-2-mer513-707
4×SO4;
Assess
Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B).
1l6j
monomer29-444
2×ZN; 3×CA;
Assess
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor
8k5y
monomer38-444
2×ZN; 3×CA; 1×VP6; 1×2HP;
Assess
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor
8k5v
monomer38-444
2×ZN; 3×CA; 1×VOC;
Assess
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor
8k5w
monomer38-444
2×ZN; 3×CA; 1×VOO;
Assess
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor
8k5x
monomer39-444
2×ZN; 3×CA; 1×VOZ;
Assess
proMMP-9desFnII complexed to JNJ0966 INHIBITOR
5ue4
monomer40-443
2×ZN; 3×CA; 1×SO4;
Assess
proMMP-9desFnII
5ue3
monomer41-443
2×ZN; 3×CA; 2×SO4;
Assess
Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9)
5th6
monomer41-443
2×ZN; 3×CA;
Assess
Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn…
4jij
monomer107-444
1×AZI; 2×ZN; 1×CA; 2×SR; 1×PGO; 2×EDO; 1×PEG; 1×GOL;
Assess
Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP…
4h3x
monomer107-444
2×ZN; 3×CA; 1×10B; 6×GOL; 1×PGO;
Assess
Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4
5cuh
monomer107-444
2×ZN; 3×CA; 1×LTQ; 2×EDO; 1×PGO;
Assess
Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn…
4jqg
monomer107-444
1×AZI; 2×ZN; 2×CA; 1×SR; 5×EDO; 1×GOL; 1×PGO;
Assess
Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains
4h2e
monomer107-444
2×ZN; 2×CA; 6×PEG; 3×ACT; 2×BCN;
Assess
Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.
4h1q
monomer110-444
2×ZN; 4×CA; 1×0XX;
Assess
MMP-9 active site mutant with barbiturate inhibitor
2ovx
monomer110-443
2×ZN; 5×CA; 3×CL; 1×4MR;
Assess
MMP-9 active site mutant with phosphinate inhibitor
2ovz
monomer110-443
2×ZN; 5×CA; 3×CL; 1×5MR;
Assess
MMP-9 active site mutant with iodine-labeled carboxylate inhibitor
2ow0
monomer110-443
2×ZN; 4×CA; 4×CL; 1×6MR;
Assess
MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor
2ow1
monomer110-443
2×ZN; 4×CA; 3×CL; 1×7MR;
Assess
MMP9-inhibitor complex
1gkc
monomer110-443
5×CA; 1×NFH; 2×ZN;
Assess
Crystal structure of MMP9 in complex with inhibitor BE4.
6esm
monomer112-444
2×ZN; 3×CA; 1×B9Z; 1×PZE;
Assess
Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain
4wzv
monomer112-444
1×E40; 2×ZN; 3×CA; 1×EDO; 2×PGO; 2×PEG;
Assess
Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9 catalyti…
4xct
monomer113-444
1×N73; 2×ZN; 3×CA; 2×DMS; 4×EDO; 1×GOL; 2×PGO; 1×BUD;
Assess
Crystal structure of the catalytic domain of MMP-9 in complex with a selective sugar-conjugated ary…
5i12
monomer113-444
2×ZN; 3×CA; 1×H27; 1×EDO; 1×DMS; 1×GOL;
Assess
MMP-9 active site mutant with difluoro butanoic acid inhibitor
2ow2
monomer113-443
2×ZN; 3×CA; 2×CL; 1×8MR;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1ck7.1.Amonomer0.6928-704
1×ZN; 1×CA;48.47
Assess
1gxd.1.Amonomer0.53220-656
28.53
Assess